|
Free Research Report Download:
The Cancer Market Outlook To 2014
Free Pharmaceutical Market Research Reports
Biotechnology
Corporate & Fiscal
Drug Delivery
Health Products
Hospital Markets
Indication Areas
Medical Devices
Prescription Medicines
R&D
Custom Research
Pharmaceutical Events & Conferences
Contact
Terms & Conditions
Privacy
Business Market Research
Energy Market Research
Financial Market Research
Pharmaceutical Market Research
Telecoms Market Research
|
Home > Market Research > Prescription Medicines > The Pharmaceutical Market: Philippines
Espicom’s in-depth pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. Each report opens with an outlook section that provides analysis of the market, 5-year market forecasts, national data projections, market outlook and key developments such as regulation, pricing/reimbursement, intellectual property, health facilities and government policy. The report also provides extensive background information, population trends, health status, health expenditure, organisation & administration, hospital services, medical personnel, healthcare development, market access information, trade data for raw materials and finished products and essential industry contacts. Included with the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year.
The Philippines is one of the poorer countries in the ASEAN region. Administration of the health sector is highly devolved to local government units. This can make planning and co-ordination difficult. Health expenditure is low, both in absolute terms and as a percentage of GDP. The country attracts a degree of overseas aid, although it is reportedly a difficult place in which to undertake healthcare projects.
Changes to be brought by the controversial Cheaper Medicine Bill will impact the Philippines pharmaceutical market in a number of areas, including IP laws, competition and drug price control mechanisms. The market is expected to be especially volatile in the short term.
The government has been criticised in the past for not doing enough to promote generics and has recently stepped up its efforts, launching Project 100 in 2008 for example, which promises to offer cheap generics at 100 public hospitals around the country.
Parallel imports have increased and the government has urged retailers and wholesalers to stock more generics, as part of its campaign to reduce the price of many essential medicines.
Highly detailed report content
MARKET OUTLOOK
Key national data projections
Pharmaceutical Market Analysis
Current market size
Market structure
Unique 5-year market projections
Imports
Domestic manufacturing
Exports
Research & development
Pharmaceutical regulatory analysis
Including regulation, pricing & reimbursement and intellectual property
Pharmaceutical distribution
Healthcare analysis
Including demographics, healthcare system, health expenditure, healthcare infrastructure and personnel
Top of Page
Table of Contents
EXECUTIVE SUMMARY 1
Introduction 2
Pharmaceutical Market Analysis . 4
Size . 4
Market Structure . 4
Generics Sector 4
Lupin Acquires Majority Stake in Multicare Pharmaceuticals Philippines . 5
Projections & Outlook . 5
Cheaper Medicines Law 6
Imports 8
Parallel Imports 9
Impact of Parallel Imports on Pharmaceutical Manufacturers 9
Background of controversies 10
Domestic Manufacturing . 14
Domestic Production . 14
Domestic Producers 15
Biotechnology 15
Philippines First Biopharmaceutical Manufacturing Plant . 16
Government to Produce Vaccines under Biotech Initiative 16
Government Likely to Invest in BioChem Informatics Centre (BIC) 16
Exports 17
Research & Development . 17
Pharmaceutical Regulatory Analysis 18
Pharmaceutical Regulation . 18
National Drug Policy 18
Pharmaceutical Registration/Drug Approval Process 18
Labelling 19
Clinical trials 20
Fast Track Registrations 20
Cheaper Medicines Law 20
Pricing & Reimbursement . 21
Intellectual Property 21
DoH Wants Patent Period Shortened by 50% 21
Counterfeit Drugs 22
Pharmaceutical Distribution 22
Distributors 22
PHILIPPINES PHARMA OUTLOOK
Pharma Outlook espicom BUSINESS INTELLIGENCE
ii Quarter I 2010
Wholesaling & Retailing 23
Government Low-Cost Drug Outlets and Community Based Drug Outlets 24
Healthcare Analysis 25
Demographics . 25
Population . 25
Birth Rate . 26
Death Rate 26
Infant Mortality . 26
Life Expectancy at Birth . 26
Public Health . 26
Causes of Death 26
Incidence of Communicable Diseases . 26
Incidence of Non-communicable Diseases 26
HIV/AIDS . 26
Healthcare System 27
Health Expenditure . 28
Healthcare Infrastructure 29
Healthcare Personnel . 30
DIRECTORY 31
Government Organisations . 31
Trade Associations . 31
Methodology & Sources . 32
PHARMA OUTLOOK PHILIPPINES
Pharma Outlook espicom BUSINESS INTELLIGENCE
Quarter I 2010 iii
List of Tables
Summary of Key Data Projections, 2010-2015 . 3
Summary of the Philippines Pharmaceutical Market, 2010 . 4
Market Projections, 2010-2015 . 6
SWOT Analysis of the Philippines Pharmaceutical Market, 2010 . 7
Imports of Pharmaceuticals by Category, 2003-2007 (US$000s) 8
Import Trends (US$000s) . 8
Leading Suppliers of Raw Materials, 2007 (US$000s) . 8
Leading Suppliers of Medicaments, 2007 (US$000s) 9
Prices of Parallel Imported Medicines (Pesos) 2008 . 11
Registered Drug Manufacturers, 1994-2003 . 14
Registered Drug Manufacturers and Traders by Region, 2003 . 14
PHAP Members, 2009 . 15
Exports of Pharmaceuticals, 2003-2007 (US$000s) . 17
Export Trends (US$000s) . 17
Leading Destinations, 2007 (US$000s) . 17
Registered Pharmaceutical Suppliers, 1994-2003 . 23
Drug Wholesalers/Retailers by Region, 2003 . 23
Summary of Demographic Data, 2005/2007 25
Projected Population, 2010-2015 . 25
Healthcare Expenditure, 2005 28
Projected Health Expenditure, 2010-2015 . 28
Hospitals & Beds, 2005 29
Projected Number of Physicians, 2010-2015 30
For full details, please email keithw@cmsinfo.com
Top of Page
Buy now!
Top of Page
|
|
